Skip to content

Multilevel Peer-to-Peer HPV Vaccination and Wellness Educational Program in School Based Health Centers

Multilevel Peer-to-Peer HPV Vaccination and Wellness Educational Program in School Based Health Centers

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07412743
Acronym
PEER
Enrollment
4000
Registered
2026-02-17
Start date
2026-01-12
Completion date
2029-06-01
Last updated
2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

School Health Services

Brief summary

School-based health centers (SBHCs) are an important setting to improve health through detecting, managing and preventing chronic illness. Too few people are educated about the human papillomavirus (HPV), which can prevent tens of thousands of deaths from cancer each year. PEER will evaluate a program to increase health and wellness and the use of SBHCs for primary and preventive care. If successful, PEER could significantly increase the use of SBHCs, and decrease HPV-associated cancers and, thus, reduce the burden of cancer in the United States.

Interventions

BEHAVIORALMailers

Letter and fact sheet (infographic) mailed to caregivers of 9-14 year-olds and to teens 15-18, with optional phone call for "confidential patients" aged 15-18.

BEHAVIORALProvider Materials

Clinic team/staff training based on qualitative interviews, recommended strategies and evidence-based interventions. Training materials include FAQs and Smart phrases. FAQs and informational sheets containing the same content as the mailers distributed in clinic to teen SBHC patients and their caregivers.

BEHAVIORALPeer-to-Peer Educational Sessions

Educational sessions delivered in schools by OSBHA interns. Session content includes SBHC information and HPV awareness.

Sponsors

Kaiser Permanente
Lead SponsorOTHER
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

The PEER study is a concurrent stepped wedge and patient randomized trial that will take place in 9 School Based Health Centers (SBHCs) in Oregon serviced by Multnomah County Health Department (MC) clinics. All clusters start in control and cross over in a randomized, staggered fashion, with all eventually receiving the intervention.

Eligibility

Sex/Gender
ALL
Age
9 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Aged 9-18 * New or established patients * Flagged if due for an HPV vaccine

Exclusion criteria

\- None

Design outcomes

Primary

MeasureTime frameDescription
Rate of Vaccination for HPV (n of patients with HPV vaccination/n of patients eligible for vaccination)6 and 12 monthsVaccination among eligible clinic patients, and time to vaccination

Secondary

MeasureTime frameDescription
Rates of new patients to the clinic (n of new patients/n of established patients)6 and 12 monthsNew patients seen (vs. prior seen pts.) - New patient characteristics (age, rural)
Rate of use of other SBHC services (primary care visits, wellness assessments) (n of patients with primary care visits/n of new and established patients)6 and 12 monthsUse of other SBHC services and visits among eligible clinic patients
Rate of vaccination for other adolescent vaccinations (COVID-19, flu, Meningitis, or uptick of other vax's (TDAP, MMR, etc.)) (n of patients with additional vaccination among new and eligible clinic patients)6 and 12 monthsVaccination among eligible clinic patients, and time to vaccination

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAmanda Petrik, PhD

Kaiser Permanente

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 2, 2026